Competitive vs non-competitive inhibition — explain with graphs

Question

Distinguish between competitive and non-competitive inhibition of enzymes. How does each type affect the enzyme kinetics curve (rate vs substrate concentration graph)?

Solution — Step by Step

An enzyme inhibitor is a molecule that reduces or blocks enzyme activity. Inhibitors are important in metabolism regulation and are the basis of many drugs (aspirin inhibits COX enzymes, many antibiotics inhibit bacterial enzymes).

Two fundamental types based on where the inhibitor binds:

Competitive inhibitor: binds at the active site — the same site as the substrate
Non-competitive inhibitor: binds at a site other than the active site (allosteric site)

In competitive inhibition, the inhibitor molecule has a structure similar to the substrate. It competes with the substrate for binding at the active site.

Mechanism:

Inhibitor (I) and substrate (S) compete for the same active site
When inhibitor binds: Enzyme-Inhibitor (EI) complex forms but no product is made
When substrate binds: normal enzyme-substrate reaction occurs

Key property: Competitive inhibition is reversible by increasing substrate concentration. If you add enough substrate, it will “outcompete” the inhibitor. At infinitely high substrate, the inhibition is overcome.

Effect on Vmax and Km:

$V_{max}$ remains unchanged (at saturating substrate, all active sites have substrate)
$K_m$ increases (apparent affinity for substrate decreases — need more substrate to achieve half-maximal rate)

Example: Malonate inhibits succinate dehydrogenase (competes with succinate). Sulfadiazine (sulfa drug) inhibits bacterial DHPS by competing with PABA.

In non-competitive inhibition, the inhibitor binds to an allosteric site (a different site from the active site). This binding changes the shape of the enzyme’s active site through a conformational change.

Mechanism:

Inhibitor binds elsewhere; the active site still accepts substrate
But the enzyme-substrate complex doesn’t function efficiently → reduced product formation
Can form EI or ESI complexes, but ESI produces product at reduced rate (or not at all)

Key property: Non-competitive inhibition is NOT reversed by adding more substrate. Since the inhibitor binds elsewhere, substrate cannot displace it.

Effect on Vmax and Km:

$V_{max}$ decreases (even at maximum substrate, product formation rate is reduced)
$K_m$ remains unchanged (the enzyme’s affinity for substrate at the active site is unaltered)

Example: Cyanide inhibits cytochrome c oxidase non-competitively (binds Fe in the enzyme, not at substrate site). Heavy metals like mercury and lead can non-competitively inhibit many enzymes.

Rate vs [Substrate] graph (Michaelis-Menten curve):

No inhibitor: curve rises and levels off at $V_{max}$
Competitive inhibitor: curve rises more slowly (reaches $V_{max}$ at higher substrate concentration) but eventually reaches the same $V_{max}$ . The curve appears “shifted to the right.”
Non-competitive inhibitor: curve reaches a lower $V_{max}$ . The half-maximal rate ( $K_m$ ) is at the same substrate concentration as without inhibitor. The curve is “compressed downward.”

Summary: on the graph, if the curves all meet at the same plateau → competitive inhibition. If the plateau (Vmax) is lower → non-competitive inhibition.

Why This Works

The difference in kinetics reflects the mechanism of inhibition. Competitive inhibition is a competition — which molecule (S or I) wins more binding events depends on their relative concentrations. Flood the enzyme with substrate and it overwhelms the inhibitor.

Non-competitive inhibition is not a competition — it changes the enzyme’s catalytic power itself. Even if every active site has a substrate, the enzyme can’t work as well because its shape is distorted. You can’t overcome this by adding more substrate.

This distinction has major pharmacological importance. Most enzyme-targeting drugs work competitively (like statins competing with HMG-CoA for HMG-CoA reductase, or methotrexate competing with folate for DHFR). Non-competitive inhibitors include nerve agents like sarin (inhibit acetylcholinesterase).

Alternative Method

Comparison table:

Feature	Competitive	Non-competitive
Binding site	Active site	Allosteric site
Structural similarity to substrate	Yes	Not required
Reversible by high [S]?	Yes	No
Effect on Vmax	No change	Decreases
Effect on Km	Increases (apparent)	No change
Graph shape	Shifts right	Drops down

For NEET MCQs, the question “Which inhibitor changes Vmax but not Km?” always has the answer: non-competitive. And “Which changes Km but not Vmax?” → competitive. These are 99% reliable. Memorize: Competitive Inhibition = Changed Km (C for Changed, C for Competitive). Non-competitive = Changed Vmax (both start with N… No change to Km).

Common Mistake

Students often confuse which quantity ( $V_{max}$ or $K_m$ ) changes in each type. The most reliable way to remember: in competitive inhibition, the inhibitor competes at the active site — but you can win the competition by adding more substrate — so theoretically the enzyme can still reach its maximum rate ( $V_{max}$ unchanged). You just need more substrate to get there ( $K_m$ increases). In non-competitive inhibition, the enzyme is “damaged” or altered regardless of substrate — so the maximum rate is reduced ( $V_{max}$ decreased) but the enzyme’s affinity for substrate at its active site is fine ( $K_m$ unchanged).

Question

Solution — Step by Step

Why This Works

Alternative Method

Common Mistake

Try These Next